FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004227911> ?p ?o ?g. }

• W2004227911 endingPage "1459.e4" @default.
• W2004227911 startingPage "1453" @default.
• W2004227911 abstract "RM-131, a synthetic ghrelin agonist, greatly accelerates gastric emptying of solids in patients with type 2 diabetes and delayed gastric emptying (DGE). We investigated the safety and effects of a single dose of RM-131 on gastric emptying and upper gastrointestinal (GI) symptoms in patients with type 1 diabetes and previously documented DGE.In a double-blind cross-over study, 10 patients with type 1 diabetes (age, 45.7 ± 4.4 y; body mass index, 24.1 ± 1.1 kg/m(2)) and previously documented DGE were assigned in random order to receive a single dose of RM-131 (100 μg, subcutaneously) or placebo. Thirty minutes later, they ate a radiolabeled solid-liquid meal containing EggBeaters (ConAgra Foods, Omaha, NE), and then underwent 4 hours of gastric emptying and 6 hours of colonic filling analyses by scintigraphy. Upper GI symptoms were assessed using a daily diary, gastroparesis cardinal symptom index (total GCSI-DD) and a combination of nausea, vomiting, fullness, and pain (NVFP) scores (each rated on a 0-5 scale).At screening, participants' mean level of hemoglobin A1c was 9.1% ± 0.5%; their total GCSI-DD score was 1.66 ± 0.38 (median, 1.71), and their total NVFP score was 1.73 ± 0.39 (median, 1.9). The t1/2 of solid gastric emptying was 84.9 ± 31.6 minutes when subjects were given RM-131 and 118.7 ± 26.7 when they were given a placebo. The median difference (Δ)was 33.9 minutes (interquartile range [IQR] -12, -49), or -54.7% (IQR, -21%,-110%). RM-131 decreased gastric retention of solids at 1 hour (P = .005) and 2 hours (P = .019). Numeric differences in t1/2 for gastric emptying of liquids, solid gastric emptying lag time, and colonic filling at 6 hours were not significant. Total GCSI-DD scores were 0.79 on placebo (IQR, 0.75, 2.08) and 0.17 on RM-131 (IQR, 0.00, 0.67; P = .026); NVFP scores were lower on RM-131 (P = .041). There were no significant adverse effects.RM-131 significantly accelerates gastric emptying of solids and reduces upper GI symptoms in patients with type 1 diabetes and documented DGE." @default.
• W2004227911 created "2016-06-24" @default.
• W2004227911 creator A5009138609 @default.
• W2004227911 creator A5016581938 @default.
• W2004227911 creator A5017598516 @default.
• W2004227911 creator A5019887105 @default.
• W2004227911 creator A5034412938 @default.
• W2004227911 creator A5040287595 @default.
• W2004227911 creator A5053211662 @default.
• W2004227911 creator A5055945168 @default.
• W2004227911 creator A5083048130 @default.
• W2004227911 date "2013-11-01" @default.
• W2004227911 modified "2023-10-11" @default.
• W2004227911 title "The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus" @default.
• W2004227911 cites W1502294688 @default.
• W2004227911 cites W1520349489 @default.
• W2004227911 cites W1525765510 @default.
• W2004227911 cites W1531474084 @default.
• W2004227911 cites W1557583413 @default.
• W2004227911 cites W1842959935 @default.
• W2004227911 cites W1921855376 @default.
• W2004227911 cites W1964891913 @default.
• W2004227911 cites W1978005566 @default.
• W2004227911 cites W1978458176 @default.
• W2004227911 cites W1996200834 @default.
• W2004227911 cites W1997587937 @default.
• W2004227911 cites W2003659660 @default.
• W2004227911 cites W2004873215 @default.
• W2004227911 cites W2017392274 @default.
• W2004227911 cites W2037694332 @default.
• W2004227911 cites W2049233278 @default.
• W2004227911 cites W2051753034 @default.
• W2004227911 cites W2052367163 @default.
• W2004227911 cites W2054526512 @default.
• W2004227911 cites W2062013642 @default.
• W2004227911 cites W2069420729 @default.
• W2004227911 cites W2070318946 @default.
• W2004227911 cites W2080936688 @default.
• W2004227911 cites W2085536990 @default.
• W2004227911 cites W2094161736 @default.
• W2004227911 cites W2104883150 @default.
• W2004227911 cites W2107965234 @default.
• W2004227911 cites W2115012618 @default.
• W2004227911 cites W2120560084 @default.
• W2004227911 cites W2122114281 @default.
• W2004227911 cites W2138018572 @default.
• W2004227911 cites W2146079901 @default.
• W2004227911 cites W2153335875 @default.
• W2004227911 cites W2165046753 @default.
• W2004227911 cites W2169057220 @default.
• W2004227911 cites W2316983199 @default.
• W2004227911 cites W2616625093 @default.
• W2004227911 doi "https://doi.org/10.1016/j.cgh.2013.04.019" @default.
• W2004227911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3805699" @default.
• W2004227911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23639598" @default.
• W2004227911 hasPublicationYear "2013" @default.
• W2004227911 type Work @default.
• W2004227911 sameAs 2004227911 @default.
• W2004227911 citedByCount "90" @default.
• W2004227911 countsByYear W20042279112014 @default.
• W2004227911 countsByYear W20042279112015 @default.
• W2004227911 countsByYear W20042279112016 @default.
• W2004227911 countsByYear W20042279112017 @default.
• W2004227911 countsByYear W20042279112018 @default.
• W2004227911 countsByYear W20042279112019 @default.
• W2004227911 countsByYear W20042279112020 @default.
• W2004227911 countsByYear W20042279112021 @default.
• W2004227911 countsByYear W20042279112022 @default.
• W2004227911 countsByYear W20042279112023 @default.
• W2004227911 crossrefType "journal-article" @default.
• W2004227911 hasAuthorship W2004227911A5009138609 @default.
• W2004227911 hasAuthorship W2004227911A5016581938 @default.
• W2004227911 hasAuthorship W2004227911A5017598516 @default.
• W2004227911 hasAuthorship W2004227911A5019887105 @default.
• W2004227911 hasAuthorship W2004227911A5034412938 @default.
• W2004227911 hasAuthorship W2004227911A5040287595 @default.
• W2004227911 hasAuthorship W2004227911A5053211662 @default.
• W2004227911 hasAuthorship W2004227911A5055945168 @default.
• W2004227911 hasAuthorship W2004227911A5083048130 @default.
• W2004227911 hasBestOaLocation W20042279111 @default.
• W2004227911 hasConcept C119060515 @default.
• W2004227911 hasConcept C126322002 @default.
• W2004227911 hasConcept C134018914 @default.
• W2004227911 hasConcept C142724271 @default.
• W2004227911 hasConcept C204787440 @default.
• W2004227911 hasConcept C27081682 @default.
• W2004227911 hasConcept C2777180221 @default.
• W2004227911 hasConcept C2778769438 @default.
• W2004227911 hasConcept C2779422922 @default.
• W2004227911 hasConcept C2780580376 @default.
• W2004227911 hasConcept C2780852908 @default.
• W2004227911 hasConcept C3020479747 @default.
• W2004227911 hasConcept C555293320 @default.
• W2004227911 hasConcept C71924100 @default.
• W2004227911 hasConcept C90924648 @default.
• W2004227911 hasConceptScore W2004227911C119060515 @default.
• W2004227911 hasConceptScore W2004227911C126322002 @default.
• W2004227911 hasConceptScore W2004227911C134018914 @default.

• next